Novo CEO pressed by Senate to chop prices of being overweight, diabetic issues drugs CEO Lars Fruergaard Jørgensen told lawmakers the company would think about new talks with insurers about the checklist costs of Wegovy and copyright whenever they pledge to maintain the medicines on their own formularies. The deal https://dave-s-hot-chicken-calori05949.getblogs.net/63160604/indicators-on-healthcare-news-you-should-know